Does breastfeeding protect against allergic rhinitis during childhood? A meta-analysis of prospective studies

A Mimouni Bloch1, D Mimouni, M Mimouni

  • 1The Institute for Child Development and Pediatric Neurology Unit, Sourasky Medical Center, Tel Aviv, Israel. blochy@netvision.net.il

Insights

Exclusive breastfeeding for the first three months protects infants from allergic rhinitis. This protective effect was observed in children with and without a family history of atopy, though statistical significance was borderline.

Area of Science:

  • Pediatrics
  • Immunology
  • Allergy Research

Background:

  • The relationship between breastfeeding and atopic conditions like allergic rhinitis is debated.
  • Previous studies have yielded controversial results regarding breastfeeding's impact on allergic rhinitis development.

Purpose of the Study:

  • To systematically review prospective studies on exclusive breastfeeding's association with allergic rhinitis.
  • To evaluate the protective effect of early exclusive breastfeeding on allergic rhinitis in children.

Main Methods:

  • Systematic review of prospective studies published between 1966 and 2000.
  • Searched MEDLINE databases and reviewed reference lists.
  • Assessed methodological quality, breastfeeding duration/exclusivity, and controlled for confounding variables.

Main Results:

  • Six prospective studies met the inclusion criteria.
  • The overall odds ratio for breastfeeding's protective effect was 0.74 (95% CI 0.54-1.01).
  • In studies of children with a family history of atopy, the odds ratio was 0.87 (95% CI 0.48-1.58).

Conclusions:

  • Exclusive breastfeeding for the first three months offers protection against allergic rhinitis.
  • This protective effect was substantial, even in children with a family history of atopy.
  • Further large-scale prospective studies with rigorous methodology and extended follow-up are recommended.
Abstract

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...